That's interesting, because it's a very unusual case where you have another state government review foreign purchases internally. Over here, I'm hoping that this is triggered as well. I think it merits it.
Also, it's important to note that there's no monetary threshold for the national security review. So that people are aware, the minister has two separate processes. He has the net benefit to Canada clause, and that has been tested recently. We've seen U.S. Steel, for example, where the Canadian government had to bring them to court because, even in spite of conditions being put on them, they've pulled back from those conditions. Separate and independent from that is the new national security provision that's available.
I want to switch quickly to another gear with regard to branch plant development versus that of home plant development, research and design and so forth. Where does most of that take place in terms of patent development and then bringing it to market? Does it take place in a home plant or does it take place in subsidiary or branch plants?